Report Detail
Global and China Parkinson’s Disease Drugs Market Insights, Forecast to 2026
- RnM3402456 |
- 14 October, 2020 |
- Global |
- 132 Pages |
- QYResearch |
- Pharma & Healthcare
Parkinson’s Disease Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson’s Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Parkinson’s Disease Drugs market is segmented into
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Segment by Application, the Parkinson’s Disease Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Parkinson’s Disease Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Parkinson’s Disease Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Parkinson’s Disease Drugs Market Share Analysis
Parkinson’s Disease Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Parkinson’s Disease Drugs business, the date to enter into the Parkinson’s Disease Drugs market, Parkinson’s Disease Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis
F. Hoffmann-La Roche
AbbVie
Teva Pharmaceutical Industries
UCB Inc.
STADA Arzneimittel
GlaxoSmithKline
Bausch Health
Merck
Impax Laboratories
1 Study Coverage
- 1.1 Parkinson’s Disease Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Parkinson’s Disease Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Parkinson’s Disease Drugs Market Size Growth Rate by Type
- 1.4.2 Oral
- 1.4.3 Transdermal
- 1.4.4 Subcutaneous
- 1.4.5 Intestinal Infusion
- 1.5 Market by Application
- 1.5.1 Global Parkinson’s Disease Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacy
- 1.5.3 Retail Pharmacy
- 1.5.4 Online Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Parkinson’s Disease Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Parkinson’s Disease Drugs Revenue 2015-2026
- 2.1.2 Global Parkinson’s Disease Drugs Sales 2015-2026
- 2.2 Global Parkinson’s Disease Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Parkinson’s Disease Drugs Historical Market Size by Region (2015-2020)
- 2.3.1 Global Parkinson’s Disease Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Parkinson’s Disease Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Parkinson’s Disease Drugs Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Parkinson’s Disease Drugs Sales Forecast by Region (2021-2026)
- 2.4.2 Global Parkinson’s Disease Drugs Revenue Forecast by Region (2021-2026)
3 Global Parkinson’s Disease Drugs Competitor Landscape by Players
- 3.1 Global Top Parkinson’s Disease Drugs Sales by Manufacturers
- 3.1.1 Global Parkinson’s Disease Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Global Parkinson’s Disease Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Parkinson’s Disease Drugs Manufacturers by Revenue
- 3.2.1 Global Parkinson’s Disease Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Parkinson’s Disease Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Parkinson’s Disease Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Parkinson’s Disease Drugs Revenue in 2019
- 3.2.5 Global Parkinson’s Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Parkinson’s Disease Drugs Price by Manufacturers
- 3.4 Global Parkinson’s Disease Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Parkinson’s Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Parkinson’s Disease Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Parkinson’s Disease Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Parkinson’s Disease Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Parkinson’s Disease Drugs Sales by Type (2015-2020)
- 4.1.2 Global Parkinson’s Disease Drugs Revenue by Type (2015-2020)
- 4.1.3 Parkinson’s Disease Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Parkinson’s Disease Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Parkinson’s Disease Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Parkinson’s Disease Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Parkinson’s Disease Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Parkinson’s Disease Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Parkinson’s Disease Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Parkinson’s Disease Drugs Sales by Application (2015-2020)
- 5.1.2 Global Parkinson’s Disease Drugs Revenue by Application (2015-2020)
- 5.1.3 Parkinson’s Disease Drugs Price by Application (2015-2020)
- 5.2 Parkinson’s Disease Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Parkinson’s Disease Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Parkinson’s Disease Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Parkinson’s Disease Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
- 6.1 China Parkinson’s Disease Drugs Market Size YoY Growth 2015-2026
- 6.1.1 China Parkinson’s Disease Drugs Sales YoY Growth 2015-2026
- 6.1.2 China Parkinson’s Disease Drugs Revenue YoY Growth 2015-2026
- 6.1.3 China Parkinson’s Disease Drugs Market Share in Global Market 2015-2026
- 6.2 China Parkinson’s Disease Drugs Market Size by Players (International and Local Players)
- 6.2.1 China Top Parkinson’s Disease Drugs Players by Sales (2015-2020)
- 6.2.2 China Top Parkinson’s Disease Drugs Players by Revenue (2015-2020)
- 6.3 China Parkinson’s Disease Drugs Historic Market Review by Type (2015-2020)
- 6.3.1 China Parkinson’s Disease Drugs Sales Market Share by Type (2015-2020)
- 6.3.2 China Parkinson’s Disease Drugs Revenue Market Share by Type (2015-2020)
- 6.3.3 China Parkinson’s Disease Drugs Price by Type (2015-2020)
- 6.4 China Parkinson’s Disease Drugs Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 China Parkinson’s Disease Drugs Sales Forecast by Type (2021-2026)
- 6.4.2 China Parkinson’s Disease Drugs Revenue Forecast by Type (2021-2026)
- 6.4.3 China Parkinson’s Disease Drugs Price Forecast by Type (2021-2026)
- 6.5 China Parkinson’s Disease Drugs Historic Market Review by Application (2015-2020)
- 6.5.1 China Parkinson’s Disease Drugs Sales Market Share by Application (2015-2020)
- 6.5.2 China Parkinson’s Disease Drugs Revenue Market Share by Application (2015-2020)
- 6.5.3 China Parkinson’s Disease Drugs Price by Application (2015-2020)
- 6.6 China Parkinson’s Disease Drugs Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 China Parkinson’s Disease Drugs Sales Forecast by Application (2021-2026)
- 6.6.2 China Parkinson’s Disease Drugs Revenue Forecast by Application (2021-2026)
- 6.6.3 China Parkinson’s Disease Drugs Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Parkinson’s Disease Drugs Market Size YoY Growth 2015-2026
- 7.2 North America Parkinson’s Disease Drugs Market Facts & Figures by Country
- 7.2.1 North America Parkinson’s Disease Drugs Sales by Country (2015-2020)
- 7.2.2 North America Parkinson’s Disease Drugs Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Parkinson’s Disease Drugs Market Size YoY Growth 2015-2026
- 8.2 Europe Parkinson’s Disease Drugs Market Facts & Figures by Country
- 8.2.1 Europe Parkinson’s Disease Drugs Sales by Country
- 8.2.2 Europe Parkinson’s Disease Drugs Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Parkinson’s Disease Drugs Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Parkinson’s Disease Drugs Market Facts & Figures by Country
- 9.2.1 Asia Pacific Parkinson’s Disease Drugs Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Parkinson’s Disease Drugs Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Parkinson’s Disease Drugs Market Size YoY Growth 2015-2026
- 10.2 Latin America Parkinson’s Disease Drugs Market Facts & Figures by Country
- 10.2.1 Latin America Parkinson’s Disease Drugs Sales by Country
- 10.2.2 Latin America Parkinson’s Disease Drugs Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Parkinson’s Disease Drugs Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Parkinson’s Disease Drugs Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Parkinson’s Disease Drugs Sales by Country
- 11.2.2 Middle East and Africa Parkinson’s Disease Drugs Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Novartis
- 12.1.1 Novartis Corporation Information
- 12.1.2 Novartis Description and Business Overview
- 12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Novartis Parkinson’s Disease Drugs Products Offered
- 12.1.5 Novartis Recent Development
- 12.2 F. Hoffmann-La Roche
- 12.2.1 F. Hoffmann-La Roche Corporation Information
- 12.2.2 F. Hoffmann-La Roche Description and Business Overview
- 12.2.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 F. Hoffmann-La Roche Parkinson’s Disease Drugs Products Offered
- 12.2.5 F. Hoffmann-La Roche Recent Development
- 12.3 AbbVie
- 12.3.1 AbbVie Corporation Information
- 12.3.2 AbbVie Description and Business Overview
- 12.3.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 AbbVie Parkinson’s Disease Drugs Products Offered
- 12.3.5 AbbVie Recent Development
- 12.4 Teva Pharmaceutical Industries
- 12.4.1 Teva Pharmaceutical Industries Corporation Information
- 12.4.2 Teva Pharmaceutical Industries Description and Business Overview
- 12.4.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Products Offered
- 12.4.5 Teva Pharmaceutical Industries Recent Development
- 12.5 UCB Inc.
- 12.5.1 UCB Inc. Corporation Information
- 12.5.2 UCB Inc. Description and Business Overview
- 12.5.3 UCB Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 UCB Inc. Parkinson’s Disease Drugs Products Offered
- 12.5.5 UCB Inc. Recent Development
- 12.6 STADA Arzneimittel
- 12.6.1 STADA Arzneimittel Corporation Information
- 12.6.2 STADA Arzneimittel Description and Business Overview
- 12.6.3 STADA Arzneimittel Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 STADA Arzneimittel Parkinson’s Disease Drugs Products Offered
- 12.6.5 STADA Arzneimittel Recent Development
- 12.7 GlaxoSmithKline
- 12.7.1 GlaxoSmithKline Corporation Information
- 12.7.2 GlaxoSmithKline Description and Business Overview
- 12.7.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 GlaxoSmithKline Parkinson’s Disease Drugs Products Offered
- 12.7.5 GlaxoSmithKline Recent Development
- 12.8 Bausch Health
- 12.8.1 Bausch Health Corporation Information
- 12.8.2 Bausch Health Description and Business Overview
- 12.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Bausch Health Parkinson’s Disease Drugs Products Offered
- 12.8.5 Bausch Health Recent Development
- 12.9 Merck
- 12.9.1 Merck Corporation Information
- 12.9.2 Merck Description and Business Overview
- 12.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Merck Parkinson’s Disease Drugs Products Offered
- 12.9.5 Merck Recent Development
- 12.10 Impax Laboratories
- 12.10.1 Impax Laboratories Corporation Information
- 12.10.2 Impax Laboratories Description and Business Overview
- 12.10.3 Impax Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Impax Laboratories Parkinson’s Disease Drugs Products Offered
- 12.10.5 Impax Laboratories Recent Development
- 12.11 Novartis
- 12.11.1 Novartis Corporation Information
- 12.11.2 Novartis Description and Business Overview
- 12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Novartis Parkinson’s Disease Drugs Products Offered
- 12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Parkinson’s Disease Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Parkinson’s Disease Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Parkinson’s Disease Drugs . Industry analysis & Market Report on Parkinson’s Disease Drugs is a syndicated market report, published as Global and China Parkinson’s Disease Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Parkinson’s Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
